Last: | $21.605 |
---|---|
Change Percent: | 0.28% |
Open: | $21.56 |
Close: | $21.605 |
High: | $22.31 |
Low: | $21.39 |
Volume: | 125,885 |
Last Trade Date Time: | 04/26/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.605 | $21.56 | $21.605 | $22.31 | $21.39 | 125,885 | 04-26-2024 |
$21.62 | $22.23 | $21.62 | $22.3 | $21.5 | 324,153 | 04-25-2024 |
$22.27 | $22.8 | $22.27 | $22.8 | $22.09 | 98,156 | 04-24-2024 |
$22.51 | $22.83 | $22.51 | $22.83 | $22 | 143,503 | 04-23-2024 |
$22.5 | $22.64 | $22.5 | $22.87 | $22.29 | 168,397 | 04-22-2024 |
$22.64 | $21.76 | $22.64 | $23.18 | $21.76 | 305,739 | 04-19-2024 |
$22.02 | $21.75 | $22.02 | $22.39 | $21.5 | 124,605 | 04-18-2024 |
$21.56 | $21.51 | $21.56 | $21.78 | $20.94 | 121,826 | 04-17-2024 |
$21.25 | $20.75 | $21.25 | $21.88 | $20.75 | 141,243 | 04-16-2024 |
$20.66 | $22.65 | $20.66 | $22.78 | $20.43 | 77,611 | 04-15-2024 |
$22.17 | $22.78 | $22.17 | $22.8 | $21.82 | 104,414 | 04-12-2024 |
$22.36 | $21.045 | $22.36 | $22.55 | $20.895 | 575,986 | 04-11-2024 |
$21.15 | $20.51 | $21.15 | $21.25 | $20.39 | 127,366 | 04-10-2024 |
$21 | $21.51 | $21 | $21.89 | $19.48 | 126,802 | 04-09-2024 |
$21.41 | $21 | $21.41 | $21.49 | $20.8 | 65,314 | 04-08-2024 |
$21.15 | $21.21 | $21.15 | $21.52 | $20.875 | 203,629 | 04-05-2024 |
$21.42 | $21.39 | $21.42 | $21.86 | $21.0199 | 73,069 | 04-04-2024 |
$21.32 | $20.83 | $21.32 | $21.63 | $20.68 | 53,678 | 04-03-2024 |
$21.24 | $21.15 | $21.24 | $21.88 | $21.025 | 48,751 | 04-02-2024 |
$21.7 | $21.21 | $21.7 | $21.74 | $20.56 | 98,421 | 04-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Silence Therapeutics Plc Company Name:
SLN Stock Symbol:
NASDAQ Market:
Published findings demonstrate zerlasiran was well-tolerated and significantly reduced Lp(a) after single and multiple dosing Silence Therapeutics plc, Nasdaq: SLN (“Silence” or the “Company”), an experienced and innovative biotechnology company committed to ...
Silence Therapeutics Plc (NASDAQ: SLN) reported a loss for 2023 on Wednesday. The company reported a loss per share of (38.9) pence for 2023, narro...